Correlation Between Abbott Laboratories and Xvivo Perfusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abbott Laboratories and Xvivo Perfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abbott Laboratories and Xvivo Perfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abbott Laboratories and Xvivo Perfusion AB, you can compare the effects of market volatilities on Abbott Laboratories and Xvivo Perfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abbott Laboratories with a short position of Xvivo Perfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abbott Laboratories and Xvivo Perfusion.

Diversification Opportunities for Abbott Laboratories and Xvivo Perfusion

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Abbott and Xvivo is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Abbott Laboratories and Xvivo Perfusion AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xvivo Perfusion AB and Abbott Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abbott Laboratories are associated (or correlated) with Xvivo Perfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xvivo Perfusion AB has no effect on the direction of Abbott Laboratories i.e., Abbott Laboratories and Xvivo Perfusion go up and down completely randomly.

Pair Corralation between Abbott Laboratories and Xvivo Perfusion

Considering the 90-day investment horizon Abbott Laboratories is expected to generate 0.87 times more return on investment than Xvivo Perfusion. However, Abbott Laboratories is 1.15 times less risky than Xvivo Perfusion. It trades about 0.14 of its potential returns per unit of risk. Xvivo Perfusion AB is currently generating about -0.31 per unit of risk. If you would invest  11,407  in Abbott Laboratories on August 28, 2024 and sell it today you would earn a total of  406.00  from holding Abbott Laboratories or generate 3.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Abbott Laboratories  vs.  Xvivo Perfusion AB

 Performance 
       Timeline  
Abbott Laboratories 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable fundamental drivers, Abbott Laboratories is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Xvivo Perfusion AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Abbott Laboratories and Xvivo Perfusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abbott Laboratories and Xvivo Perfusion

The main advantage of trading using opposite Abbott Laboratories and Xvivo Perfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abbott Laboratories position performs unexpectedly, Xvivo Perfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xvivo Perfusion will offset losses from the drop in Xvivo Perfusion's long position.
The idea behind Abbott Laboratories and Xvivo Perfusion AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance